These data implicate excessive heterochromatin formation as a pathological feature of ataxia telangiectasia and ALS, highlighting the potential of HDAC inhibitors as a means to prevent neuronal cell death. The gene discussed is HDAC9; the disease is amyotrophic lateral sclerosis.